Concepedia

Roberto Ferrara

RF

Statistics

Publications

64

Citations

7.1K

H-Index

32

Active since

1995

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Institut Gustave Roussy

Istituti di Ricovero e Cura a Carattere Scientifico

Mario Negri Institute for Pharmacological Research

University of Milan

Roberto Ferrara is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1995–2025

64

Publications

64

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

Ian G. McKeith, Teodoro del Ser, PierFranco Spano et al. · The Lancet · 2000 · 1.2K citations

Medicine, Neurology, Pharmacotherapy +14

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

Kathryn C. Arbour, Laura Mezquita, Niamh M. Long et al. · Journal of Clinical Oncology · 2018 · 1.1K citations · Full text

Pharmacy, Oncology, Pharmacology +17

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Laura Mezquita, Édouard Auclin, Roberto Ferrara et al. · JAMA Oncology · 2018 · 951 citations · Full text

Life Sciences, Immunology, Oncology +17

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Roberto Ferrara, Laura Mezquita, Matthieu Texier et al. · JAMA Oncology · 2018 · 738 citations · Full text

Medicine, Oncology, Pharmacology +14

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria

Mélodie Tazdait, Laura Mezquita, J. Lahmar et al. · European Journal of Cancer · 2017 · 351 citations

Medicine, Oncology, Immunotherapy +14

1–5 of 64